Volume 29, Issue 5 e70115
ORIGINAL ARTICLE

Efficacy of Subcutaneous Immunoglobulin in the Postoperative Management After Pediatric Living Donor Liver Transplantation

Yuta Hirata

Corresponding Author

Yuta Hirata

Division of Gastroenterological, General and Transplant Surgery, Department of Surgery, Jichi Medical University, Shimotsuke City, Japan

Correspondence:

Yuta Hirata ([email protected])

Search for more papers by this author
Yukihiro Sanada

Yukihiro Sanada

Division of Gastroenterological, General and Transplant Surgery, Department of Surgery, Jichi Medical University, Shimotsuke City, Japan

Search for more papers by this author
Kiichiro Takadera

Kiichiro Takadera

Division of Gastroenterological, General and Transplant Surgery, Department of Surgery, Jichi Medical University, Shimotsuke City, Japan

Search for more papers by this author
Ryosuke Akimoto

Ryosuke Akimoto

Division of Gastroenterological, General and Transplant Surgery, Department of Surgery, Jichi Medical University, Shimotsuke City, Japan

Search for more papers by this author
Takahiko Omameuda

Takahiko Omameuda

Division of Gastroenterological, General and Transplant Surgery, Department of Surgery, Jichi Medical University, Shimotsuke City, Japan

Search for more papers by this author
Toshio Horiuchi

Toshio Horiuchi

Division of Gastroenterological, General and Transplant Surgery, Department of Surgery, Jichi Medical University, Shimotsuke City, Japan

Search for more papers by this author
Noriki Okada

Noriki Okada

Division of Gastroenterological, General and Transplant Surgery, Department of Surgery, Jichi Medical University, Shimotsuke City, Japan

Search for more papers by this author
Taiichi Wakiya

Taiichi Wakiya

Division of Gastroenterological, General and Transplant Surgery, Department of Surgery, Jichi Medical University, Shimotsuke City, Japan

Search for more papers by this author
Yasuharu Onishi

Yasuharu Onishi

Division of Gastroenterological, General and Transplant Surgery, Department of Surgery, Jichi Medical University, Shimotsuke City, Japan

Search for more papers by this author
Yasunaru Sakuma

Yasunaru Sakuma

Division of Gastroenterological, General and Transplant Surgery, Department of Surgery, Jichi Medical University, Shimotsuke City, Japan

Search for more papers by this author
Naohiro Sata

Naohiro Sata

Division of Gastroenterological, General and Transplant Surgery, Department of Surgery, Jichi Medical University, Shimotsuke City, Japan

Search for more papers by this author
First published: 10 June 2025

Funding: The authors received no specific funding for this work.

ABSTRACT

Background

The usefulness of subcutaneous immunoglobulin (SCIG) for the treatment of hypogammaglobulinemia has been reported, but there are no reports in the field of pediatric liver transplantation (LT). We herein report the therapeutic efficacy of SCIG in the postoperative management after pediatric living donor LT (LDLT).

Methods

Subjects were 112 pediatric recipients who underwent LDLT between March 2012 and December 2021. SCIG administration was started in February 2017 and performed in 43 patients with hypogammaglobulinemia (< 870 mg/dL). Intravenous immunoglobulin (IVIG) administration was performed in 69 patients before January 2017. SCIG was administered subcutaneously at 130 (82–238) mg/kg/dose every week from postoperative day (POD) 2 until discharge.

Results

The preoperative serum IgG level in the SCIG group was 906 (249–1987) mg/dL, and the IgG level at the end of LDLT was 491 (246–823) mg/dL, showing a significant difference (p < 0.001). The median IgG levels in the SCIG group after LT were 697, 607, 579, 691, 665, and 795 mg/dL at 1, 2, 3, 4, and 5 weeks after surgery and after discharge, respectively. The incidence of bacteremia was significantly lower in the SCIG group than in the IVIG group (p = 0.025). The recipient's survival rate was not significantly different between the SCIG and IVIG groups (p = 0.080), but the recipient's survival rate in the SCIG group was 100%. The multivariate analysis revealed that the IVIG group and CMV viremia were a significant risk factors for bacteremia (p = 0.023 and 0.001, respectively).

Conclusions

Postoperative SCIG administration effectively maintained serum IgG levels and was useful for preventing bacteremia.

Conflicts of Interest

The authors declare no conflicts of interest.

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.